Shoulder

Global Elbow Replacement Market to surpass $200.4 million by 2031, at a CAGR of 4.2%, says Coherent Market Insights

Retrieved on: 
Monday, April 8, 2024
Longevity, Rheumatoid arthritis, Prevalence, Partnership, Patient, AAOS, Elbow, Polyethylene, American Academy, Acquisition, Motion, Quality of life, Injury, Integra, Shoulder, Metal, Partial, Key, Pain, Osteoarthritis, USD, Collection, Plumbing

Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.

Key Points: 
  • Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.
  • As per the market research report, the elbow replacement market was valued at USD 144.2 million in 2023, with a projected CAGR of 4.2% during the forecast period 2024-2031.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/6663
    In terms of type, the elbow replacement market is segmented into partial elbow replacement and total elbow replacement.
  • Partial elbow replacement is expected to dominate the market, owing to its less invasive nature and shorter recovery time compared to total elbow replacement.

Global Elbow Replacement Market to surpass $200.4 million by 2031, at a CAGR of 4.2%, says Coherent Market Insights

Retrieved on: 
Monday, April 8, 2024
Longevity, Rheumatoid arthritis, Prevalence, Partnership, Patient, AAOS, Elbow, Polyethylene, American Academy, Acquisition, Motion, Quality of life, Injury, Integra, Shoulder, Metal, Partial, Key, Pain, Osteoarthritis, USD, Collection, Plumbing

Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.

Key Points: 
  • Elbow replacement surgery is a medical procedure that involves replacing a damaged or diseased elbow joint with an artificial implant.
  • As per the market research report, the elbow replacement market was valued at USD 144.2 million in 2023, with a projected CAGR of 4.2% during the forecast period 2024-2031.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/6663
    In terms of type, the elbow replacement market is segmented into partial elbow replacement and total elbow replacement.
  • Partial elbow replacement is expected to dominate the market, owing to its less invasive nature and shorter recovery time compared to total elbow replacement.

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

Retrieved on: 
Monday, March 25, 2024
Knee, Health, Regeneration, Sport, Shoulder, Hip, UFC Performance Institute, Partnership, Patient, Life, Research, Athlete, Surgeon, Octagon, SNN, Safety, Sports medicine, UFC, Smith & Nephew, Rehabilitation

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global brands in all of sports.

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global brands in all of sports.
  • “We’re thrilled to have Smith+Nephew join us for the first time as an Official UFC Partner,” said Robby Miller, Vice President, UFC Global Partnerships.
  • “Through hard work, significant investment, and groundbreaking innovations like the UFC Performance Institute, UFC has become the industry leader in athlete health and safety in combat sports.
  • We are proud to partner with UFC and share a common goal to get patients back in the game quickly, safely, and effectively,” said Scott Schaffner, President Sports Medicine, Smith+Nephew.

Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy

Retrieved on: 
Wednesday, March 20, 2024
CELU, Diagnosis, Shoulder, Biologics license application, Disease, Risk, Patient, Microsoft Exchange Server, Stem cell, IND, Facioscapulohumeral muscular dystrophy, Regenerative medicine, FDA, BLA, FSHD, Muscular dystrophy, Food, Pharmaceutical industry

FLORHAM PARK, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that it has submitted a request to the U.S. Food and Drug Administration (FDA) for orphan drug designation for its off-the-shelf, placental-derived cell therapy, PDA-002, for treating Facioscapulohumeral Muscular Dystrophy (FSHD).

Key Points: 
  • FLORHAM PARK, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that it has submitted a request to the U.S. Food and Drug Administration (FDA) for orphan drug designation for its off-the-shelf, placental-derived cell therapy, PDA-002, for treating Facioscapulohumeral Muscular Dystrophy (FSHD).
  • Orphan drug designation is a status given to drugs that show the potential to treat, prevent or diagnose serious or life-threatening diseases that affect fewer than 200,000 people in the U.S.
  • Earlier, Celularity received FDA Investigational New Drug Application clearance for PDA-002 in FSHD and plans to commence a phase 1/2 study in the second half of 2024.
  • The trial serves as an important component for submitting a Biologics License Application (BLA) to the FDA in the future as a potential treatment for FSHD and other types of muscular dystrophy.

Summit Health Names Timothy Reish, M.D., Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry

Retrieved on: 
Tuesday, April 2, 2024
Health, Surgery, Practice Management, Physical Therapy, Other Health, Managed Care, General Health, Knee, Shoulder, Orthopedic surgery, Patient, Franklin Avenue, Research, Pain management, Elbow, Summit Health, Summit, Sports medicine, Dentistry

Timothy Reish, M.D., has been named Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry of Summit Health’s NY South region.

Key Points: 
  • Timothy Reish, M.D., has been named Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry of Summit Health’s NY South region.
  • He has been a practicing Orthopedic Surgeon in New York City for more than 20 years.
  • “We are thrilled that Dr. Reish will be leading three of our key departments that are essential to the health and well-being of our patients throughout their lifetime,” said Christine Masterson, M.D., executive vice president at Summit Health.
  • “I look forward to helping our Orthopedics, and Sports Medicine, Pain Management and Podiatry departments stay at the forefront of healthcare by offering the latest advancements and cutting-edge techniques in the fields of Orthopedics and Sports Medicine, Pain Management and Podiatry,” said Dr. Reish.

HomeWell Franchising Celebrates 100 Franchise Owners and $100M in Annual System Revenue

Retrieved on: 
Tuesday, April 2, 2024
Other Health, Managed Care, General Health, Professional Services, Consumer, Small Business, Public Relations, Investor Relations, Women, Seniors, Communications, Practice Management, Health, Growth, Shoulder, Record, Road, Map

The completion of this organizational milestone marks 100 unique franchise owners nationwide and the franchise’s first $100 million in annual system revenue.

Key Points: 
  • The completion of this organizational milestone marks 100 unique franchise owners nationwide and the franchise’s first $100 million in annual system revenue.
  • HomeWell Franchising Inc. is a premier franchisor with over 100 franchise owners representing more than 170 territories across the United States.
  • HomeWell has been recognized as a Franchise Business Review Top 100 low-investment franchise, an Inc. 5000 company, and consecutively ranked among the nation’s top franchises in Entrepreneur magazine’s Franchise 500®.
  • For more information on HomeWell or to explore franchise opportunities, visit HomeWell Care Services or HomeWell Care Services Franchising .

Prime Insurance Company Obtains Defense Verdict in Louisiana Courts

Retrieved on: 
Thursday, March 21, 2024
Professional Services, Trucking, Rail, Transport, Legal, Insurance, Other Transport, Injury, Recreation, Accident, Shoulder, AM Best, Rail transport

Prime Insurance Company obtained a defense verdict on March 5, 2024, in the United State District Court Eastern District of Louisiana.

Key Points: 
  • Prime Insurance Company obtained a defense verdict on March 5, 2024, in the United State District Court Eastern District of Louisiana.
  • Prime Insurance Company strategically resolved the lower value claim with the plaintiff engineer in the first car.
  • Rick J. Lindsey, President, CEO and Chairman of Prime Insurance Company states, “We offered the plaintiff $100,000 pre-trial which the plaintiff refused.
  • For more information on Prime Insurance Company, visit www.primeis.com .

Procter & Gamble Brings Relief to Residents Affected by Tornadoes in Ohio and Indiana

Retrieved on: 
Monday, March 18, 2024
Men, Family, Philanthropy, Consumer, Environment, Retail, Foundation, Other Consumer, Women, Natural Disasters, Other Philanthropy, Home Goods, Old Spice, Disaster, Partnership, Bounty, Pantene, Tide, Walmart, Olay, Tornado, P&G, Power, Hygiene, Febreze, Secrecy, Shoulder, Head & Shoulders, Multimedia, Property insurance

P&G Disaster Relief is activating to support recovery efforts in Ohio and Indiana in collaboration with Walmart and Matthew 25: Ministries, an international humanitarian aid and disaster relief organization.

Key Points: 
  • P&G Disaster Relief is activating to support recovery efforts in Ohio and Indiana in collaboration with Walmart and Matthew 25: Ministries, an international humanitarian aid and disaster relief organization.
  • A Tide Loads of Hope Mobile Laundry Unit, powered by Matthew 25: Ministries, will provide free, full-service laundry to affected residents and responders.
  • People can bring clothes (up to two loads per household) to be washed, dried, and folded free of charge.
  • *
    Powerful tornadoes and storms struck central Indiana and Ohio, resulting in loss of life and damage to homes and communities.

ArteraAI and Movember Announce New Relationship

Retrieved on: 
Tuesday, March 12, 2024
Technology, Medical Devices, Men, Philanthropy, Health, Consumer, Foundation, Artificial Intelligence, Oncology, Prostate Cancer UK, Organization, Face, Movember, Shoulder, Prostate cancer, MMAI, Disease, Stratosphere, Men's Health, Cancer, Medicine, Neoplasm, ESMO, Biomedical Research

“We are privileged to stand shoulder to shoulder with industry leaders in the battle against prostate cancer,” said Andre Esteva, CEO and co-founder of ArteraAI.

Key Points: 
  • “We are privileged to stand shoulder to shoulder with industry leaders in the battle against prostate cancer,” said Andre Esteva, CEO and co-founder of ArteraAI.
  • The study successfully validated ArteraAI's prognostic model in advanced prostate cancer, demonstrating stronger prognostic correlations than individual clinical factors.
  • ArteraAI looks forward to its continued work with these organizations as there are several ongoing initiatives in the early development phase.
  • For more information on ArteraAI, visit Artera.ai .

REGENATIVE LABS' LATEST PUBLISHED STUDY DEMONSTRATES THE SAFETY AND EFFICACY OF WHARTON'S JELLY CONNECTIVE TISSUE ALLOGRAFT FOR ROTATOR CUFF TEARS

Retrieved on: 
Thursday, April 4, 2024
Knee, MDPI, Stiffness, Shoulder, Safety, Hip, Wharton's jelly, Rotator cuff, Patient, Research, Rehabilitation, Quality of life, Manager, Efficacy, WOMAC, Regenerative medicine, Quality, Literature, Spine, Orthopedic surgery, Pain, Calendar, Physician, Injury, WJ, Medicine, Dentistry

PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.

Key Points: 
  • PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.
  • Patients in need of rotator cuff repairs often seek minimally invasive options, making Wharton's Jelly a promising alternative for musculoskeletal defects.
  • Utilizing the structural connective tissue allografts has allowed many patients to avoid surgery altogether and significantly improve their quality of life."
  • The study titled "Safety and Efficacy of Wharton's Jelly Connective Tissue Allograft for Rotator Cuff Tears," was published by MDPI and can be accessed in its entirety here.